Efficacy of Olfactive Training on Loss of Smell and Taste Caused by SARS CoV2 COVID-19 (Covid-Smell)

NCT ID: NCT07190911

Last Updated: 2025-10-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-18

Study Completion Date

2022-03-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate efficiency of two months of olfactive training on olfactory and taste loss secondary to covid-19. We will compare 2 groups : olfactive training group versus no olfactive training group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to evaluate efficiency of two months of olfactive training on olfactory and taste loss secondary to covid-19. We will compare 2 groups : olfactive training group versus no olfactive training group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID - 19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

To prove this efficiency, a parallel prospective comparative study appear to be one of the best the way.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

olfactory training arm

with a daily olfactory training during 2 month

Group Type EXPERIMENTAL

Olfactory rehabilitation consists of smelling a series of spices every day for 2 months

Intervention Type OTHER

Olfactory rehabilitation consists of smelling a series of spices every day for 2 months: vanilla, coffee, dill, thyme, cinnamon, cloves, lavender, coriander, light vinegar, mint, and cumin.

This rehabilitation is based on the protocols proposed by SFORL (French ORL society) and Oleszkiewicz et al.8

Allergies to certain spices will be noted at the start of the study:

* in known allergy: change by another spice which belongs to the same chemical category.
* in case of allergies to several scents: patient is not included in the study.
* in case of allergy appearing during participation: clinical evaluation by ENT, change by another spice which belongs to the same chemical category.
* in case of allergies to several scents occuring during participation: patient is excluded from the study.

no olfactory training

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Olfactory rehabilitation consists of smelling a series of spices every day for 2 months

Olfactory rehabilitation consists of smelling a series of spices every day for 2 months: vanilla, coffee, dill, thyme, cinnamon, cloves, lavender, coriander, light vinegar, mint, and cumin.

This rehabilitation is based on the protocols proposed by SFORL (French ORL society) and Oleszkiewicz et al.8

Allergies to certain spices will be noted at the start of the study:

* in known allergy: change by another spice which belongs to the same chemical category.
* in case of allergies to several scents: patient is not included in the study.
* in case of allergy appearing during participation: clinical evaluation by ENT, change by another spice which belongs to the same chemical category.
* in case of allergies to several scents occuring during participation: patient is excluded from the study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* SARS-CoV-2 infection suspect or confirmed
* supported by CHU Guadeloupe
* with brutal olfactory or taste loss
* affiliated or beneficiary of a social security scheme
* informed consent signed

Exclusion Criteria

* recent rhinosinusitis, less than 6 months
* lingual pathology
* communication disorder
* Patients subject to a justice safeguard
* Allergy to several spices that are part of the rehabilitation set
* Pregnant or breastfeeding women
* Absence of signed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de la Guadeloupe

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Suzy Duflo, MD PhD

Role: PRINCIPAL_INVESTIGATOR

CHU de la Guadeloupe

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu de La Guadeloupe

Pointe-à-Pitre, , Guadeloupe

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Guadeloupe

Related Links

Access external resources that provide additional context or updates about the study.

https://dumas.ccsd.cnrs.fr/dumas-04551904

Medical thesis of Ms. Nordera, entitled "Study on the Effectiveness of Olfactory Rehabilitation for Dysosmia and Dysgeusia Following SARS-CoV-2 Infection

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-A02606-33

Identifier Type: REGISTRY

Identifier Source: secondary_id

PAP_RI2_2020/17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

COVID-19 Anosmia Study
NCT04495816 COMPLETED PHASE2